Transforming Health

In this episode, our experts shine a light on the benefits of endoscopy in the long-term management of inflammatory bowel disease (IBD).   Despite the valuable role of endoscopy, there are still barriers to its adoption in care pathways. We explore why that is, and how we need to shift perceptions and work collaboratively to improve long-term patient outcomes in IBD.  This recording was organised and funded by Johnson & Johnson.September 2025CP-530931

In this episode, we talk about the importance of shared decision-making in helping patients achieve a “life of possibility”, especially in complex illnesses like multiple myeloma. Our experts discuss the barriers that prevent patients and HCPs from being equal partners, how shared decision-making leads to better decision-making, and the critical role of advocacy groups in empowering patients to have a greater say in their treatment pathway.This recording was organised and funded by Johnson & Johnson August 2025CP-530923 | CP-530918

In the final episode of Season 2, we look at the future of healthcare in Central Europe and the Baltics, a diverse region that covers almost one third of EU countries.  Tuba Atahan, Managing Director, and Laura Saar, Market Access Director, for Central Europe and Baltics delve into the current barriers to healthcare access in the region – such as the growing disparity in multiple myeloma care – and discuss innovative solutions that will help close the gap. This recording was organised and funded by Johnson & Johnson November 2024CP-485355 | CP-485428

In this episode, we find out how the healthcare industry and academic institutions are working together to find solutions to a decreasing healthcare workforce.  Giuseppe Pompilio, Director of Market Access, Johnson & Johnson, Italy, joins us to discuss the results of a recent academic partnership and the new healthcare roles that are key to progressing patient care. This recording was organised and funded by Johnson & Johnson October 2024CP-479290 | CP-479287

In this episode, we explore the current pressure on Europe’s healthcare resources and how partnerships can help reduce inefficiencies and take us forward – with examples from the Nordic region. As the need for value-based healthcare becomes more apparent, we speak to Sofia Iqbal, Real-World Evidence Strategic Partnerships Lead for EMEA, about how collaboration identifies innovative solutions that could ultimately improve patient care. This recording was organised and funded by Johnson & Johnson October 2024CP-478884 | CP-478875

In this episode, we’re speaking with an expert in Switzerland to better understand the role of research and development, manufacturing, and supply chain in creating an ecosystem that fosters healthcare innovation.We also discuss some potential real-world solutions and explore how talented people, in the right environment, make Switzerland such a unique hub for science, innovation and excellence in Europe.This recording was organised and funded by Johnson & Johnson July 2024CP-463603